secwatch.observer — SEC 8-K summary
======================================

Issuer:     Health Catalyst, Inc. (HCAT)
CIK:        0001636422
Form:       8-K
Filed at:   2026-01-23T23:59:59+00:00
Accession:  0001636422-26-000010
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Health Catalyst CCO Kevin Freeman to Depart, Remain as Senior Advisor
---------------------------------------------------------------------

- Kevin Freeman will cease serving as Chief Commercial Officer on February 1, 2026.
- Company expects to enter a separation agreement and independent contractor agreement for senior advisor role starting February 2, 2026.
- Separation benefits under Executive Severance Plan as summarized in May 2025 proxy statement.
- Transition intended to enable smooth handover of commercial responsibilities.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1636422/000163642226000010/0001636422-26-000010-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1636422/000163642226000010/hcat-20260120.htm
  HTML page:      https://secwatch.observer/filing/0001636422-26-000010

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer